Insider · CIK 0001312907
Garber Alan M
Reports to the SEC for 2 companies · BOSTON, MA
Transactions
50
Companies
2
Filings
13
CIK
0001312907
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-15 | VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award | +$15K |
| 2026-07-15 | VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award | +$15K |
| 2026-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
| 2026-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2026-04-15 | VRTXVERTEX PHARMACEUTICALS INC / MA · Deferred Stock UnitsA Award | +$15K |
| 2025-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
| 2025-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2024-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2024-03-21 | EXELEXELIXIS, INC.M Exercise/Conversion | +$460K |
| 2024-03-21 | EXELEXELIXIS, INC.S Sale | −$461K |
| 2024-03-21 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2023-06-01 | EXELEXELIXIS, INC. · Option (right to buy)A Award | — |
| 2023-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
| 2023-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2023-02-21 | EXELEXELIXIS, INC.M Exercise/Conversion | +$252K |
| 2023-02-21 | EXELEXELIXIS, INC.S Sale | −$700K |
| 2023-02-21 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2022-05-26 | EXELEXELIXIS, INC. · Option (right to buy)A Award | — |
| 2022-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2022-03-01 | EXELEXELIXIS, INC.M Exercise/Conversion | +$125K |
| 2022-03-01 | EXELEXELIXIS, INC.S Sale | −$447K |
| 2022-03-01 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2021-05-27 | EXELEXELIXIS, INC. · Option (right to buy)A Award | — |
| 2021-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2021-03-15 | EXELEXELIXIS, INC.M Exercise/Conversion | +$135K |
| 2021-03-15 | EXELEXELIXIS, INC.S Sale | −$944K |
| 2021-03-15 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2020-06-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
| 2020-06-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2020-05-22 | EXELEXELIXIS, INC.S Sale | −$882K |
| 2020-05-21 | EXELEXELIXIS, INC. · Option (right to buy)A Award | — |
| 2020-02-14 | EXELEXELIXIS, INC.S Sale | −$263K |
| 2020-01-07 | EXELEXELIXIS, INC.M Exercise/Conversion | +$137K |
| 2020-01-07 | EXELEXELIXIS, INC.M Exercise/Conversion | +$331K |
| 2020-01-07 | EXELEXELIXIS, INC.S Sale | −$1.57M |
| 2020-01-07 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2020-01-07 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2019-06-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
| 2019-06-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2019-05-23 | EXELEXELIXIS, INC. · Option (right to buy)A Award | — |
| 2019-04-01 | EXELEXELIXIS, INC.M Exercise/Conversion | +$88.8K |
| 2019-04-01 | EXELEXELIXIS, INC.S Sale | −$360K |
| 2019-04-01 | EXELEXELIXIS, INC.M Exercise/Conversion | +$68.6K |
| 2019-04-01 | EXELEXELIXIS, INC.S Sale | −$360K |
| 2019-04-01 | EXELEXELIXIS, INC. · Option (right to buy)S Sale | — |
| 2019-04-01 | EXELEXELIXIS, INC. · Option (right to buy)S Sale | — |
| 2019-01-08 | EXELEXELIXIS, INC.M Exercise/Conversion | +$46.8K |
| 2019-01-08 | EXELEXELIXIS, INC.S Sale | −$259K |
| 2019-01-08 | EXELEXELIXIS, INC. · Option (right to buy)M Exercise/Conversion | — |
| 2018-06-01 | VRTXVERTEX PHARMACEUTICALS INC / MAA Award | — |
Recent filings
- 4Garber Alan M0000875320-26-000274SEC(opens sec.gov)
- 4Garber Alan M0000875320-26-000247SEC(opens sec.gov)
- 4Garber Alan M0000875320-26-000179SEC(opens sec.gov)
- 4Garber Alan M0000875320-26-000159SEC(opens sec.gov)
- 4Garber Alan M0000875320-25-000177SEC(opens sec.gov)
- 4Garber Alan M0000875320-24-000121SEC(opens sec.gov)
- 4Garber Alan M0000939767-24-000036SEC(opens sec.gov)
- 4Garber Alan M0000939767-23-000062SEC(opens sec.gov)
- 4Garber Alan M0001209191-23-027015SEC(opens sec.gov)
- 4Garber Alan M0000939767-23-000028SEC(opens sec.gov)
- 4Garber Alan M0000939767-22-000073SEC(opens sec.gov)
- 4Garber Alan M0000899243-22-016329SEC(opens sec.gov)
- 4Garber Alan M0000939767-22-000034SEC(opens sec.gov)
Companies
Address
C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE
BOSTON, MA, 02210